Point Of Care Diagnostic Solutions
Enable rapid, reliable testing closer to the patient while accelerating time-to-market with Meridian’s portfolio of molecular and immunoassay technologies. From enzymes, master mixes, amplification reagents, stabilization solutions, and custom development services to antibodies, antigens, blockers, and assay optimization technologies, we help diagnostic developers simplify development, optimize performance, and bring innovative diagnostic tests to market faster.
Designed for decentralized and near-patient testing environments, our technologies support the development of high-performing point-of-care diagnostic solutions across a broad range of applications.
Point-of-Care Testing Environments
Support rapid diagnostic testing in physician offices, urgent care centers, and outpatient settings.
Enable timely diagnostic results to support clinical decision-making in hospitals and emergency departments.
Decentralized Laboratory Networks
Extend diagnostic testing capabilities beyond centralized laboratories while maintaining assay performance and reliability.
Develop robust testing solutions for locations where laboratory infrastructure and cold-chain logistics may be limited.
Why Partner with Meridian for Point-of-Care Diagnostic Development?
Bringing a point-of-care diagnostic to market requires more than high-quality reagents, it requires technologies and expertise that help overcome development challenges, optimize performance, and support commercialization across molecular and immunoassay platforms.
Meridian provides a comprehensive portfolio of molecular and immunoassay solutions, including amplification reagents, enzymes, antibodies, antigens, blockers, assay optimization reagents, and technologies supporting lateral flow, fluorescence immunoassay (FIA), and other point-of-care diagnostic platforms, as well as custom development support. By combining proven technologies with scientific collaboration, we help diagnostic developers reduce risk, streamline development, and accelerate the path from concept to market
Molecular Technologies Supporting Point-of-Care Testing
qPCR & RT-qPCR
Isothermal Amplification Reagents
Amplification technologies that eliminate the need for thermal cycling, enabling simplified workflows and faster time-to-results. turnaround times.
Specialty Enzymes
High-performance DNA polymerases and reverse transcriptases designed to support robust molecular assay performance, including ambient-stable formats.
Stabilization Technologies
Custom Development Services
Immunoassay Technologies Supporting Point-of-Care Testing
Rapid Lateral Flow Immunoassays
Support for the development of rapid antigen and antibody tests through optimized reagents, assay optimization technologies and lateral flow solutions, enabling reliable performance in decentralized testing environments.
Fluorescence Immunoassays (FIA)
Reagents designed to support sensitive fluorescence-based detection platforms, helping developers achieve reliable performance across decentralized and near-patient testing applications.
Microfluidic and Cartridge-Based Systems
Technologies supporting integrated immunoassay workflows for automated and near-patient testing applications, enabling simplified workflows, improved usability and consistent assay performance.
Assay Optimization and Performance Enhancement
Blocking and assay optimization technologies designed to reduce non-specific binding and mitigate assay interference, helping improve sensitivity, specificity and overall assay reliability.
Custom Development Services
Benefits of Meridian's Point-of-Care Solutions
Faster Results
Rapid molecular and immunoassay workflows that support timely clinical decisions.
Simplified Development
Access ready-to-use reagents, assay components, and technical expertise that streamline development.
Reliable Performance
Deliver consistent sensitivity, specificity, and reproducibility across molecular and immunoassay platforms.
Decentralized Testing
Technologies designed for near-patient and distributed testing environments.
Ambient Stability
Molecular stabilization technologies that support ambient storage, simplified logistics, and reduced cold-chain dependence.
Accelerate Development
with Expert Partnership
Leverage Meridian’s established molecular and immunoassay technologies, custom development capabilities, and scientific expertise to reduce development timelines, overcome technical challenges, and bring innovative diagnostic solutions to market faster.
Life Science Blogs
Liquid Biopsy: Entering a New Phase in Cancer Diagnostics
What Would It Take to Bring NGS to the Point of Need
Double Trouble: Viral Co-Infections and Their Role in Cancer Progression
Smarter Library Prep for Whole Genome Sequencing
Antigens Matter: How Native and Recombinant Formats Shape Immunoassay Success
